118 related articles for article (PubMed ID: 25380681)
1. Aggregates of pseudo-Gaucher cells after treatment of chronic myeloid leukemia in blastic phase.
Helbig G; Janikowska A; Kyrcz-Krzemien S
Int J Hematol; 2015 Jan; 101(1):3-4. PubMed ID: 25380681
[No Abstract] [Full Text] [Related]
2. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic granulocytic leukemia in blastic crisis.
Canellos GP
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
[No Abstract] [Full Text] [Related]
4. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia.
Cağirgan S; Sencan M; Tombuloglu M; Ozdemir E; Hekimgil M; Büyükkeçeci F
Leuk Lymphoma; 1998 Apr; 29(3-4):423-5. PubMed ID: 9684940
[TBL] [Abstract][Full Text] [Related]
5. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
6. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
Katagiri T; Miyazawa K; Uchida Y; Hayashi S; Iwama H; Shyohji N; Kawakubo K; Shimamoto T; Inatomi Y; Kuriyama Y; Yaguchi M; Nehashi Y; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1998 Dec; 39(12):1149-56. PubMed ID: 10028846
[TBL] [Abstract][Full Text] [Related]
7. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
[No Abstract] [Full Text] [Related]
8. Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment.
Angriman F; Gutierrez Acevedo MN; Rossi MS; Gimenez Conca AD; Otero V; Arbelbide JA; Michelángelo H
Turk J Haematol; 2015 Jun; 32(2):193-4. PubMed ID: 26316496
[No Abstract] [Full Text] [Related]
9. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia.
Maiti A; Cortes J; Ferrajoli A; Estrov Z; Borthakur G; Garcia-Manero G; Jabbour E; Ravandi F; O'Brien S; Kantarjian H
Leuk Lymphoma; 2017 Sep; 58(9):1-6. PubMed ID: 28278723
[No Abstract] [Full Text] [Related]
11. [Treatment of blast crisis of chronic myeloid leukemia].
Kotlarek-Haus S
Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
[TBL] [Abstract][Full Text] [Related]
12. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
Nand S; Barton K
Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
[No Abstract] [Full Text] [Related]
13. [Chronic leukemia].
Shibata A; Narita M
Gan To Kagaku Ryoho; 1989 May; 16(5):1982-8. PubMed ID: 2658837
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation.
Milojkovic D; Ibrahim A; Reid A; Foroni L; Apperley J; Marin D
Haematologica; 2012 Mar; 97(3):473-4. PubMed ID: 22133777
[No Abstract] [Full Text] [Related]
15. [Presence of Gaucher-like cells in a case of Ph1-positive chronic myeloid leukemia with lymphoid-myeloid crisis].
Miyazawa K; Ohyashiki JH; Tauchi T; Fujieda H; Ohyashiki K; Toyama K; Enomoto Y
Rinsho Ketsueki; 1988 Sep; 29(9):1488-92. PubMed ID: 3216521
[No Abstract] [Full Text] [Related]
16. [Chronic myelogenous leukemia with blastic crisis in which expression of P-glycoprotein was associated with resistance to chemotherapy].
Utsunomiya A; Kuwazuru Y; Chuman Y; Mishige Y; Saito T; Terada A; Iwahashi M; Hanada S; Yoshimura A; Akiyama S
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1915-8. PubMed ID: 1355642
[TBL] [Abstract][Full Text] [Related]
17. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
[TBL] [Abstract][Full Text] [Related]
18. Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importance.
Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri NK; Kumar A; Saikia TK; Gopal R; Mazumdar AT; Advani SH
J Assoc Physicians India; 1988 Nov; 36(11):653-5. PubMed ID: 3248993
[No Abstract] [Full Text] [Related]
19. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
Fujisawa S; Yano K; Kobayashi M
Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
[TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
